Steroidic 5.alpha.-reductase inhibitors
US4732897A · kind A · utility
43Cited by
3References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 3, 1986 |
| Grant date | Mar 22, 1988 |
| Priority date | — |
| Expiry date | Feb 3, 2006 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/16
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to new 4-aza-17.beta.-substituted 5.alpha.-androstan-3-ones, to a process for their preparation, to pharmacological compostions containing them, and to the use of said compounds as inhibitors of androgen action by means of testosterone 5-reductase inhibition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.